IRIS Accounts Production v23.1.0.753 11331261 Board of Directors 1.5.22 30.4.23 30.4.23 false true false false true false Ordinary 1.00000 A Ordinary 1.00000 B Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure113312612022-04-30113312612023-04-30113312612022-05-012023-04-30113312612021-04-30113312612021-05-012022-04-30113312612022-04-3011331261ns16:EnglandWales2022-05-012023-04-3011331261ns15:PoundSterling2022-05-012023-04-3011331261ns11:Director12022-05-012023-04-3011331261ns11:PrivateLimitedCompanyLtd2022-05-012023-04-3011331261ns11:SmallEntities2022-05-012023-04-3011331261ns11:AuditExempt-NoAccountantsReport2022-05-012023-04-3011331261ns11:SmallCompaniesRegimeForDirectorsReport2022-05-012023-04-3011331261ns11:SmallCompaniesRegimeForAccounts2022-05-012023-04-3011331261ns11:FullAccounts2022-05-012023-04-3011331261ns11:OrdinaryShareClass12022-05-012023-04-3011331261ns11:OrdinaryShareClass22022-05-012023-04-3011331261ns11:OrdinaryShareClass32022-05-012023-04-3011331261ns11:Director22022-05-012023-04-3011331261ns11:RegisteredOffice2022-05-012023-04-3011331261ns6:CurrentFinancialInstruments2023-04-3011331261ns6:CurrentFinancialInstruments2022-04-3011331261ns6:Non-currentFinancialInstruments2023-04-3011331261ns6:Non-currentFinancialInstruments2022-04-3011331261ns6:ShareCapital2023-04-3011331261ns6:ShareCapital2022-04-3011331261ns6:RetainedEarningsAccumulatedLosses2023-04-3011331261ns6:RetainedEarningsAccumulatedLosses2022-04-3011331261ns6:FurnitureFittings2022-05-012023-04-3011331261ns6:MotorVehicles2022-05-012023-04-3011331261ns6:ComputerEquipment2022-05-012023-04-3011331261ns6:FurnitureFittings2022-04-3011331261ns6:MotorVehicles2022-04-3011331261ns6:ComputerEquipment2022-04-3011331261ns6:FurnitureFittings2023-04-3011331261ns6:MotorVehicles2023-04-3011331261ns6:ComputerEquipment2023-04-3011331261ns6:FurnitureFittings2022-04-3011331261ns6:MotorVehicles2022-04-3011331261ns6:ComputerEquipment2022-04-3011331261ns6:CostValuation2022-04-3011331261ns6:Non-currentFinancialInstruments2022-05-012023-04-3011331261ns6:DeferredTaxation2022-04-3011331261ns6:DeferredTaxation2022-05-012023-04-3011331261ns6:DeferredTaxation2023-04-3011331261ns11:OrdinaryShareClass12023-04-3011331261ns11:OrdinaryShareClass22023-04-3011331261ns11:OrdinaryShareClass32023-04-3011331261ns6:RetainedEarningsAccumulatedLosses2022-04-3011331261ns6:RetainedEarningsAccumulatedLosses2022-05-012023-04-30
REGISTERED NUMBER: 11331261 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 April 2023

for

Pass Radiology Limited

Pass Radiology Limited (Registered number: 11331261)






Contents of the Financial Statements
for the Year Ended 30 April 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Pass Radiology Limited

Company Information
for the Year Ended 30 April 2023







DIRECTORS: Dr B Pass
Mrs R Pass





REGISTERED OFFICE: 3 Park Square
Leeds
LS1 2NE





REGISTERED NUMBER: 11331261 (England and Wales)





ACCOUNTANTS: Charles Stewart & Co Limited
Chartered Accountants
3 Park Square
Leeds
LS1 2NE

Pass Radiology Limited (Registered number: 11331261)

Balance Sheet
30 April 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 24,343 34,907
Investments 5 12,000 12,000
36,343 46,907

CURRENT ASSETS
Debtors 6 46,709 30,261
Cash at bank 187,157 193,699
233,866 223,960
CREDITORS
Amounts falling due within one year 7 24,035 109,253
NET CURRENT ASSETS 209,831 114,707
TOTAL ASSETS LESS CURRENT
LIABILITIES

246,174

161,614

CREDITORS
Amounts falling due after more than one
year

8

(14,649

)

(19,336

)

PROVISIONS FOR LIABILITIES 9 (4,722 ) (6,633 )
NET ASSETS 226,803 135,645

CAPITAL AND RESERVES
Called up share capital 10 200 200
Retained earnings 11 226,603 135,445
SHAREHOLDERS' FUNDS 226,803 135,645

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Pass Radiology Limited (Registered number: 11331261)

Balance Sheet - continued
30 April 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 24 January 2024 and were signed on its behalf by:





Dr B Pass - Director


Pass Radiology Limited (Registered number: 11331261)

Notes to the Financial Statements
for the Year Ended 30 April 2023

1. STATUTORY INFORMATION

Pass Radiology Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 20% on cost
Motor vehicles - 20% on cost
Computer equipment - 20% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 2 ) .

Pass Radiology Limited (Registered number: 11331261)

Notes to the Financial Statements - continued
for the Year Ended 30 April 2023

4. TANGIBLE FIXED ASSETS
Fixtures
and Motor Computer
fittings vehicles equipment Totals
£    £    £    £   
COST
At 1 May 2022 243 65,500 1,994 67,737
Additions - - 3,127 3,127
At 30 April 2023 243 65,500 5,121 70,864
DEPRECIATION
At 1 May 2022 208 31,658 964 32,830
Charge for year 35 13,100 556 13,691
At 30 April 2023 243 44,758 1,520 46,521
NET BOOK VALUE
At 30 April 2023 - 20,742 3,601 24,343
At 30 April 2022 35 33,842 1,030 34,907

5. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£   
COST
At 1 May 2022
and 30 April 2023 12,000
NET BOOK VALUE
At 30 April 2023 12,000
At 30 April 2022 12,000

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 46,709 30,261

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Tax 11,242 13,086
Bank loan 5,303 5,303
Directors' current accounts 4,960 88,965
Accrued expenses 2,530 1,899
24,035 109,253

Pass Radiology Limited (Registered number: 11331261)

Notes to the Financial Statements - continued
for the Year Ended 30 April 2023

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2023 2022
£    £   
Bank loan 14,649 19,336

The bank loan represents a loan under HM Government Coronavirus Business Bounce Back Loan Scheme. The bank loan carries an interest rate of 2.5% per annum and it is repayable in accordance with the rules of the scheme.

9. PROVISIONS FOR LIABILITIES
2023 2022
£    £   
Deferred tax 4,722 6,633

Deferred
tax
£   
Balance at 1 May 2022 6,633
Credit to Income Statement during year (1,911 )
Balance at 30 April 2023 4,722

10. CALLED UP SHARE CAPITAL




Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
100 Ordinary £1 100 100
50 A Ordinary £1 50 50
50 B Ordinary £1 50 50
200 200

11. RESERVES
Retained
earnings
£   

At 1 May 2022 135,445
Profit for the year 121,158
Dividends (30,000 )
At 30 April 2023 226,603

12. RELATED PARTY DISCLOSURES

During the year, total dividends of £30,000 were paid to the directors .

Pass Radiology Limited (Registered number: 11331261)

Notes to the Financial Statements - continued
for the Year Ended 30 April 2023

12. RELATED PARTY DISCLOSURES - continued

During the year the company raised invoices totalling £80,000 (2022: 80,000) to Skeletal Imaging Limited a company of which Mr B Pass and Mrs R Pass are directors.

13. ULTIMATE CONTROL

The company is under the ultimate control of the directors.